Incepta to market nasal Covid vaccine
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
THURSDAY, MAY 19, 2022
THURSDAY, MAY 19, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
Incepta to market nasal Covid vaccine

Health

Tawsia Tajmim
18 December, 2021, 04:30 pm
Last modified: 19 December, 2021, 12:35 pm

Related News

  • S Korea plans to provide Covid vaccine to North
  • WTO meeting on Covid vaccine rights waiver went 'very well' -chair
  • Denmark becomes first country to suspend Covid vaccinations
  • German man gets 90 Covid-19 shots to sell forged passes
  • Corona's mass vaccination going on all over the country

Incepta to market nasal Covid vaccine

Incepta is also working on producing another protein-vaccine in collaboration with USA’s Baylor College of Medicine and Texas Children’s Hospital

Tawsia Tajmim
18 December, 2021, 04:30 pm
Last modified: 19 December, 2021, 12:35 pm
Incepta to market nasal Covid vaccine

With British biomedical firm ViraCorp, leading Bangladeshi pharmaceutical company Incepta is set to develop a unique, needle-free Covid-19 vaccine, which uses state-of-the-art intra-nasal technology.

Currently under a pre-clinical trial, this nasal vaccine is expected to hit the market in the third quarter of next year, said an Incepta Pharmaceuticals official.

"Lancaster University and ViraCorp have successfully developed this vaccine in their lab and are conducting a worldwide clinical trial. Incepta Pharmaceuticals is partnering with ViraCorp to make the vaccine commercially available in the market," an Incepta official told The Business Standard on condition of anonymity.

"We will either supply it locally or export it to other countries," added the official.

The price of the vaccine has not been fixed yet, as it will take another 7-8 months for its production. However, according to the Incepta authority, the vaccine will be very affordable.

Experts say, this vaccine features a unique formulation and delivery method which means it not only protects against Covid-19, but it can be delivered by nasal spray and transported using traditional cold transportation. This has numerous advantages compared to other vaccines currently on the market.

"Having a vaccine which can be transported easily and administered through a nasal delivery system reduces the heavy infrastructure and training requirements of a vaccination drive and will help ensure the vaccine to reach some of the world's most remote communities," said Dr Muhammad Munir, a pioneer of needleless and next-generation Covid-19 vaccine, who has taken on the role of Chief Scientific Officer at ViraCorp.

People involved with production of this vaccine said, administering this vaccine will not require anyone's help. Individuals will be able to buy the vaccine from a medical store and administer it all by themselves.

The Bangladesh government has been providing free vaccines since 7 February and so far 6.74 crore people have received their first jabs while 4.41 crore got both the doses.

Starting on Sunday, the government is set to begin administering booster doses of Covid-19 vaccines.

Asked whether the Incepta nasal vaccine will be available in pharmacies, the Incepta official said, "It depends on the government. After everyone gets both their doses, if the government asks people to buy booster doses, they can get it from us. Or, the government can buy it from us and distribute it for free."

Incepta's facility has a yearly production capacity of 180 million single doses, or 1 billion doses in multi-dose format.

"Incepta always explores ways to acquire, develop and optimize new vaccine processes as well as production technologies. This collaboration will be a milestone to provide a new delivery system making it a very attractive solution for vaccination in developing countries like ours, alongside remote communities," said Dr Abdul Muktadir, chairman and managing director, Incepta Vaccine Ltd.

Other than the nasal spray vaccine deal with ViraCorp, Incepta Vaccine Ltd has partnered with the government to produce Chinese Sinopharm vaccine and another protein-vaccine in collaboration with the USA's Baylor College of Medicine and Texas Children's Hospital.

Earlier in August, there were efforts by a group of doctors in the country to run a trial of a nasal spray vaccine, developed in Sweden's Karolinska Institute.

One of the experts in that effort, Professor Ahmedul Kabir, who is also the additional director general of Directorate General of Health Services told TBS, "Trial of that vaccine has been postponed due to complications of technology transfer from Sweden. It is uncertain when we will be able to begin that trial."

So far, no nasal vaccine initiative has received a nod to proceed with trials in the country. India's Bharat Biotech, USA's Codagenix, The University of Hong Kong of China and USA's The National Institutes of Health have completed different trial stages for nasal vaccines.

Top News / Covid-19 in Bangladesh

Covid -19 vaccine / nasal Covid-19 vaccine / Incepta

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Nearly 58% hike in bulk power price on cards
    Nearly 58% hike in bulk power price on cards
  • Illustration: TBS
    Let taka slide
  • Inflation jumps to 6.29% in April
    Inflation jumps to 6.29% in April

MOST VIEWED

  • Representational Photo
    Antibiotic packaging to be flagged red
  • With the ongoing pandemic exposing the inadequacies of our healthcare system, we must now formulate long-term solutions to protect ourselves from any future repercussions of the virus, as well as any other situation that may arise. hoto: Mumit M/TBS
    Building hospitals alone cannot prevent noncommunicable diseases: NHFB president
  • Photo: PR
    NCDC Programme marks ‘World Hypertension Day’
  • Photo: Courtesy
    67% pharmacy retailers not well-versed on antimicrobial drugs: DGDA
  • Photo collected from Guardian
    32 Covid cases reported in 24 hours
  • Representational Image. Photo: Pixabay
    Chattogram General Hospital installs oxygen generator

Related News

  • S Korea plans to provide Covid vaccine to North
  • WTO meeting on Covid vaccine rights waiver went 'very well' -chair
  • Denmark becomes first country to suspend Covid vaccinations
  • German man gets 90 Covid-19 shots to sell forged passes
  • Corona's mass vaccination going on all over the country

Features

‘The geopolitical landscape is undergoing profound change, Dhaka needs to craft proactive strategies’

‘The geopolitical landscape is undergoing profound change, Dhaka needs to craft proactive strategies’

19h | Interviews
Graphics: TBS

Facebook and Bangladeshi politicians: A new tide in mass political communication?

20h | Panorama
Despite Bangladesh having about 24,000 km of waterways, only a few hundred kilometres are covered by commercial launch services. Photo: Saad Abdullah

Utilising waterways: When common home-goers show the way

1d | Panorama
Illustration: TBS

How Putin revived Nato

1d | Panorama

More Videos from TBS

Cannes Film Festival 2022 resumes after 2 years

Cannes Film Festival 2022 resumes after 2 years

8h | Videos
Pension is coming for all

Pension is coming for all

8h | Videos
Bakery business in crisis for increased raw material prices

Bakery business in crisis for increased raw material prices

10h | Videos
Foods that have the most protein

Foods that have the most protein

10h | Videos

Most Read

1
Representative Photo: Pixabay.
Bangladesh

Microplastics found in 5 local sugar brands

2
Mushfiq Mobarak. Photo: Noor-A-Alam
Panorama

Meet the Yale professor who anchors his research in Bangladesh and scales up interventions globally

3
The story of Bangladesh becoming a major bicycle exporter
Industry

The story of Bangladesh becoming a major bicycle exporter

4
How Bangladesh can achieve edible oil self-sufficiency with local alternatives
Bazaar

How Bangladesh can achieve edible oil self-sufficiency with local alternatives

5
Govt tightens belt to relieve reserve
Economy

Govt tightens belt to relieve reserve

6
PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire
Crime

PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab